Seems wrong to me too debono.From memory, if its a transaction with a related party to a director for which the director receives an advantage then shareholder approval is generally required.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025